People · Operator
Named in public records as an officer, director or promoter · active 2017–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rapamycin Holdings, Inc. | — | Pharmaceuticals | Series A | $17.9M | $216.8M | 2017 |
Stephen Dufilho at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Dufilho on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Horsey | 1 | 2 |
| Mark H Horsey | 1 | 1 |
| Randy H Goldsmith | 1 | 1 |
| Stephen H Dufilho | 1 | 1 |
| Spangler Vaughn Carole | 1 | 1 |
| Hargrove Dan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.